Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
2.
Article in English | MEDLINE | ID: mdl-12489713

ABSTRACT

The spinal cord of 32 psittacines suffering from proventricular dilatation disease (PDD) was investigated. In six cases, a virus was isolated which upon electron microscopic examination revealed morphological details typical of members of the Paramyxoviridae. All isolates were subsequently characterized as avian paramyxovirus serotype 1 (APMV-1) by type-specific polyclonal antisera. According to their reactivity with APMV-1 specific monoclonal antibodies, the six isolates shared epitopes within the haemagglutinin-neuraminidase spike protein, distinct from pigeon-type paramyxoviruses and the LaSota vaccine strain. This grouping was further corroborated by properties of the haemagglutinin: all isolates showed a very thermosensitive haemagglutination activity and were rapid eluters. Virulence of the APMV-1 isolates in 1-day-old specific pathogen free (spf) chicken was very low, with intracerebral pathogenicity indices between 0 and 0.1. In embryonated spf chicken eggs, psittacine isolates replicated to high titres (10(8.6)-10(10.7) EID50/ml). However, they exhibited a reduced lethality over an observation time of 7 days (10(6.1)-10(8.3) ELD50/ml). In a haemagglutination inhibition test with parrot sera from birds with no history of APMV-1 vaccination, sera reacted preferentially with two isolates compared with APMV-1 vaccine strains LaSota and B1. The other four isolates exhibited a differentiated reaction pattern with the parrot sera, indicating an antigenic inhomogeneity. This is the first report of isolating very low virulent APMV-1 from neuronal tissue of parrots and implications for a possible role in slow progressing disease will be discussed.


Subject(s)
Newcastle Disease/epidemiology , Newcastle Disease/virology , Newcastle disease virus/immunology , Newcastle disease virus/pathogenicity , Psittaciformes/virology , Animals , Antibodies, Monoclonal/immunology , Chickens/virology , Female , Germany/epidemiology , Hemagglutination Tests/veterinary , Male , Newcastle disease virus/isolation & purification , Newcastle disease virus/ultrastructure , Ovum/virology , Serotyping , Specific Pathogen-Free Organisms , Spinal Cord/virology , Virulence Factors
3.
Mycoses ; 45(9-10): 411-4, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12421293

ABSTRACT

Penicillium marneffei infection is prevalent in South-East Asia and Southern China and has been considered an acquired immunodeficiency syndrome (AIDS)-defining disease. This report focuses on the oral and facial manifestations of P. marneffei infection in a 28-year-old Thai male patient with AIDS. The clinical, mycological and ultrastructural features are described.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Dermatomycoses/microbiology , Mycoses/microbiology , Penicillium/isolation & purification , Adult , Dermatomycoses/drug therapy , Humans , Male , Mycoses/complications , Thailand
4.
Int J Syst Evol Microbiol ; 52(Pt 1): 179-186, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11837301

ABSTRACT

A gram-negative, oxidase-positive, rod-shaped bacterium isolated from the heart of a cotton-topped tamarin was characterized by 16S rDNA sequence analysis, SDS-PAGE of whole-cell proteins, fatty acid analysis and biochemical tests. Outer-membrane proteins, iron-regulated outer-membrane proteins, lipopolysaccharides and siderophore production were studied. On the basis of the results, the organism belongs to the beta-Proteobacteria where it forms a separate line of descent, for which a novel genus and species are proposed, Brackiella oedipodis (LMG 19451T = DSM 13743T = NCIMB 13739T). Nearest phylogenetic neighbours of the new genus are Taylorella, Pelistega, Bordetella, Alcaligenes and Achromobacter.


Subject(s)
Betaproteobacteria/classification , Betaproteobacteria/enzymology , Endocarditis, Bacterial/veterinary , Monkey Diseases/microbiology , Oxidoreductases/metabolism , Saguinus , Animals , Bacterial Proteins/analysis , Betaproteobacteria/isolation & purification , DNA, Ribosomal/analysis , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/pathology , Fatty Acids/analysis , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/veterinary , Lipopolysaccharides/analysis , Molecular Sequence Data , Myocardium/pathology , Phenotype , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Siderophores/metabolism , Spectroscopy, Fourier Transform Infrared
5.
J Gen Virol ; 83(Pt 2): 463-470, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11807240

ABSTRACT

The iridovirus isolate termed cricket iridovirus (CrIV) was isolated in 1996 from Gryllus campestris L. and Acheta domesticus L. (both Orthoptera, Gryllidae). CrIV DNA shows distinct DNA restriction patterns different from those known for Insect iridescent virus type 6 (IIV-6). This observation led to the assumption that CrIV might be a new species within the family Iridoviridae. CrIV can be transmitted perorally to orthopteran species, resulting in specific, fatal diseases. These species include Gryllus bimaculatus L. and the African migratory locust Locusta migratoria migratorioides (Orthoptera, Acrididae). Analysis of genomic and host range properties of this isolate was carried out in comparison to those known for IIV-6. Host range studies of CrIV and IIV-6 revealed no differences in the peroral susceptibility in all insect species and developmental stages tested to date. Different gene loci of the IIV-6 genome were analyzed, including the major capsid protein (274L), thymidylate synthase (225R), an exonuclease (012L), DNA polymerase (037L), ATPase (075L), DNA ligase (205R) and the open reading frame 339L, which is homologous to the immediate-early protein ICP-46 of frog virus 3. The average identity of the selected viral genes and their gene products was found to be 95.98 and 95.18% at the nucleotide and amino acid level, respectively. These data led to the conclusion that CrIV and IIV-6 are not different species within the Iridoviridae family and that CrIV must be considered to be a variant and/or a novel strain of IIV-6.


Subject(s)
Genome, Viral , Gryllidae/virology , Iridovirus/genetics , Iridovirus/pathogenicity , Amino Acid Sequence , Animals , Base Sequence , Iridovirus/isolation & purification , Iridovirus/physiology , Microscopy, Electron , Molecular Sequence Data , Sequence Analysis, DNA , Viral Proteins/genetics
6.
Oral Oncol ; 37(7): 609-12, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11564584

ABSTRACT

A Shammah-induced oral leukoplakia-like lesion is described in a 44-year-old Algerian patient, who used this specific chewing tobacco since 33 years. The extended white lesion was located to the right mandibular vestibule and had a homogeneous appearance. Shammah is a chewing tobacco consisting of powdered tobacco leaves with carbonate of lime and other substances. It has been associated with oral cancer in Saudi Arabia. Histologically, acanthosis, hyperortho- and parakeratosis were seen. The spinous cell layer showed large pale staining epithelial cells with pycnotic nuclei. Atypia was not observed, however, an increase in mitotic activity was apparent. The subepithelial infiltrate was mild. Electron microscopy showed changes in the basal membrane with interruptions, duplications and triplications. Follow-up of the patient for 2 years revealed that, whenever, the patient changed the location of application, the white lesion regressed or disappeared within 4-6 weeks. Due to the composition of Shammah, the lesion induced has features of a mucosal burn. In contrast to other smokeless tobacco variants, Shammah seems to cause changes which, according to the small number of reports, may transform into oral cancer. As such, Shammah-induced oral leukoplakia-like lesions may be considered precancerous.


Subject(s)
Leukoplakia, Oral/etiology , Plants, Toxic , Tobacco, Smokeless/adverse effects , Adult , Follow-Up Studies , Humans , Leukoplakia, Oral/pathology , Male
7.
J Clin Microbiol ; 38(10): 3689-95, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11015385

ABSTRACT

A combined PCR assay was developed for the detection and typing of human polyomavirus (huPoV) in clinical samples, consisting of (i) a qualitative seminested PCR assay (snPCR) to discriminate between huPoV BK and JC and (ii) a high-throughput, quantitative TaqMan PCR assay (TM-PCR) for the general detection of huPoV. The TM-PCR detects huPoV DNA in a linear range from 10(7) to 10(1) copies per assay. In reproducibility runs, the inter- and intra-assay variabilities were < or =60 and < or =50%, respectively. The snPCR assay uses a set of four primers for the same region of the BK and JC viral genomes. In the first round of amplification, two general primers were used; in the second round, one of these general primers and two additional, BK- or JC-specific primers were used simultaneously to produce amplicons of different sizes specific for BK virus (246 bp) and JC virus (199 bp), respectively. We tested different urine dilutions in order to determine the inhibitory effects of urine on PCR amplification. Furthermore, we compared the use of native urine with DNA purified by different preparation procedures. Our results show, that a 1:10 dilution of the urine led to complete reduction of the amplification inhibition found with 6% of undiluted urine samples. In a clinical study including 600 urine specimens, our assay turned out to be fast, cheap, and reliable in both qualitative and quantitative aspects.


Subject(s)
BK Virus/classification , Bone Marrow Transplantation , JC Virus/classification , Polymerase Chain Reaction/methods , Urine/virology , BK Virus/isolation & purification , Calibration , DNA Primers , DNA, Viral/urine , Humans , JC Virus/isolation & purification , Plasmids , Reference Values , Reproducibility of Results , Time Factors , Transplantation, Homologous
8.
Virology ; 276(2): 364-75, 2000 Oct 25.
Article in English | MEDLINE | ID: mdl-11040127

ABSTRACT

Hepatitis B virus (HBV) core-derived chimeric particles carrying a Puumala (PUU) hantavirus (strain Vranica/Hällnäs) nucleocapsid (N) protein sequence (aa 1-45), alternatively inserted at three distinct positions (N-, C-terminus, or the internal region), and mosaic particles consisting of HBV core as well as core/PUU (Vranica/Hällnäs) N (aa 1-45) readthrough protein were generated. Chimeric particles carrying the insert at the N-terminus or the internal region of core induced some protective immune response in bank voles (Clethrionomys glareolus) against a subsequent PUU virus (strain Kazan) challenge; 40-50% of the animals showed markers of protection. In contrast, internal insertion of PUU strain CG18-20 N (aa 1-45) into the HBV core caused a highly protective immune response in the bank vole model. Immunizations with particles carrying aa 75-119 of PUU (CG18-20) N at the C-terminus of core verified the presence of a second, minor protective region in the N protein. A strong PUU N-specific antibody response was detected not only in bank voles immunized with chimeric particles containing internal and N-terminal fusions of PUU N protein but also in animals immunized with the corresponding mosaic particles. Except for the exclusive occurrence of antibodies directed against aa 231-240 of N in non-protected animals post virus challenge, there was no additional obvious difference in the epitope-specificity of N-specific antibodies from immunized animals prior and post virus challenge.


Subject(s)
B-Lymphocytes/immunology , Hantavirus Infections/prevention & control , Hepatitis B Core Antigens/immunology , Hepatitis B virus/immunology , Nucleocapsid/immunology , Orthohantavirus/immunology , Amino Acid Sequence , Animals , Antibodies, Viral/immunology , Arvicolinae , Epitopes, B-Lymphocyte/immunology , Escherichia coli , Orthohantavirus/classification , Hantavirus Infections/immunology , Molecular Sequence Data , Nucleocapsid Proteins , Species Specificity , Vaccines, Synthetic/chemistry , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology
9.
Bone Marrow Transplant ; 26(3): 347-50, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10967578

ABSTRACT

Hemorrhagic cystitis (HC) is a common complication following high-dose chemotherapy and bone marrow transplantation, and the treatment of virus-associated HC remains to be optimized. This is the first report on the successful use of cidofovir in a patient with HC and polyoma viruria concomitant with CMV reactivation after allogeneic BMT. Treatment led to a significant decrease in viruria and to sustained suppression of CMV reactivation. Administered with probenecid and hydration, cidofovir was well tolerated, and there were no side-effects.


Subject(s)
Antiviral Agents/therapeutic use , BK Virus , Cystitis/drug therapy , Cytomegalovirus Infections/virology , Cytomegalovirus/growth & development , Cytosine/therapeutic use , Organophosphonates , Organophosphorus Compounds/therapeutic use , Papillomavirus Infections/drug therapy , Cidofovir , Cystitis/virology , Cytomegalovirus Infections/blood , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/urine , Cytosine/analogs & derivatives , Hematuria/etiology , Hematuria/virology , Humans , Male , Middle Aged , Papillomavirus Infections/blood , Papillomavirus Infections/urine , Virus Activation/drug effects
10.
12.
Virology ; 269(2): 391-403, 2000 Apr 10.
Article in English | MEDLINE | ID: mdl-10753718

ABSTRACT

A reliable new procedure is described for the reconstitution of Sendai viral envelopes suitable for gene transfer. Both fusion and hemagglutinin-neuraminidase glycoproteins were extracted from purified Sendai virus and reconstituted together with DNA in the presence of cholesterol:sphingomyelin:phosphatidylcholine:phosphatidylethanolamin e (Chol:SM:PC:PE) in a molar ratio of 3.5:3.5:2:1. Before reconstitution, the DNA to be transferred was condensed by pretreatment with polylysine. Exogenous lipid addition and the DNA-condensation step were essential for maximal size as well as for fusogenic activity of the resulting virosomes, the analysis of which revealed (1) the absence of any genomic material originating from Sendai virus, (2) the presence of fusogenic spikes in a functional orientation, (3) the encapsulation of reporter genes, and (4) high-transfer activity for plasmids carrying the green fluorescent protein (GFP) gene and double-stranded nucleotides into different mammalian cells. Transfer rates were up to 10-fold higher than those obtained with different cationic lipids. Gene delivery by means of our lipid-enriched Sendai virosomes extends the known gene transfer strategies, including those based on Sendai virus previously published.


Subject(s)
Gene Transfer Techniques , Genetic Vectors , Polylysine , Respirovirus , Viral Envelope Proteins/genetics , Animals , Cells, Cultured , Chickens , DNA/administration & dosage , HN Protein/metabolism , Hemolysis , Microscopy, Electron
13.
J Biotechnol ; 73(2-3): 141-53, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10486924

ABSTRACT

Virus-like particles generated by the heterologous expression of virus structural proteins are able to potentiate the immunogenicity of foreign epitopes presented on their surface. In recent years epitopes of various origin have been inserted into the core antigen of hepatitis B virus (HBV) allowing the formation of chimaeric HBV core particles. Chimaeric core particles carrying the 45 N-terminal amino acids of the Puumala hantavirus nucleocapsid protein induced protective immunity in bank voles, the natural host of this hantavirus. Particles applied in the absence of adjuvant are still immunogenic and partially protective in bank voles. Although a C-terminally truncated core antigen of HBV (HBcAg delta) tolerates the insertion of extended foreign sequences, for the construction of multivalent vaccines the limited insertion capacity is still a critical factor. Recently, we have described a new system for generating HBV 'mosaic particles' in an Escherichia coli suppressor strain based on a readthrough mechanism on a stop linker located in front of the insert. Those mosaic particles are built up by both HBcAg delta and the HBcAg delta/Puumala nucleocapsid readthrough protein. The particles formed presented the 114 amino acid (aa) long hantavirus sequence, at least in part, on their surface and induced antibodies against the hantavirus sequence in bank voles. Variants of the stop linker still allowed the formation of mosaic particles demonstrating that stop codon suppression alone is sufficient for the packaging of longer foreign sequences in mosaic particles. Another approach to increase the insertion capacity is based on the simultaneous insertion of different Puumala nucleocapsid protein sequences (aa 1-45 and aa 75-119) into two different positions (aa 78 and behind aa 144) of a single HBcAg molecule. The data presented are of high relevance for the generation of multivalent vaccines requiring a high insertion capacity for foreign sequences.


Subject(s)
Hepatitis B Core Antigens/immunology , Orthohantavirus/immunology , Amino Acid Sequence , Animals , Antigens, Viral/genetics , Arvicolinae , Base Sequence , Biotechnology , Epitopes/genetics , Genetic Vectors , Orthohantavirus/genetics , Hantavirus Infections/immunology , Hantavirus Infections/prevention & control , Hepatitis B Core Antigens/genetics , Humans , Molecular Sequence Data , Plasmids/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Vaccines, Synthetic/genetics , Vaccines, Synthetic/pharmacology , Viral Vaccines/genetics , Viral Vaccines/pharmacology
14.
Intervirology ; 42(1): 51-6, 1999.
Article in English | MEDLINE | ID: mdl-10393504

ABSTRACT

Core particles of hepatitis B virus (HBV) are able to improve the immunogenicity of foreign sequences exposed on the particle surface. The insertion site in the core antigen of HBV (HBcAg) determines the surface presentation and thus the immunogenicity of the foreign sequence. For direct comparison of the value of potential insertion sites in the core antigen, we constructed vectors allowing insertions of a model marker epitope DPAFR. This epitope was inserted at the N-terminus, the c/e1 loop, behind amino acid (aa) 144 and behind aa 183 (DPAF only). In addition, we generated a mosaic construct allowing the co-expression of HBcAg and a HBcAg/DPAFR fusion protein due to a suppressor tRNA-mediated readthrough mechanism. All 6 constructs allowed the formation of chimaeric or mosaic core-like particles. Western blot analyses and a direct ELISA demonstrated the presence of the DPAFR sequence in the chimaeric and mosaic particles. Competitive ELISA and immune electron-microscopic data suggested the c/e1 loop as the insertion site of choice for presenting foreign sequences on the surface of chimaeric HBV core particles. However, the N-terminal fusion also allowed partial surface exposure of the DPAFR motif. In contrast, in particles of constructs carrying the DPAFR insert at aa position 144 or 183, respectively, the epitope seemed not to be surface accessible.


Subject(s)
Epitopes/immunology , Hepatitis B Core Antigens/genetics , Hepatitis B virus/immunology , Transformation, Genetic , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Epitopes/genetics , Genetic Vectors , Recombinant Proteins/biosynthesis
15.
J Clin Virol ; 13(1-2): 105-19, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10405897

ABSTRACT

BACKGROUND: Parallel to its technical development starting in the 1930s, electron microscopy (EM) became an important tool in basic and clinical virology. First utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. EM was applied to infected cell-cultures and also to 'dirty' specimens including urine, feces, vesicle fluid, liquor. With the implementation of molecular biological and genetic techniques, the use of diagnostic EM decreased. OBJECTIVES: (1) To give a perspective on future indications and possible uses by discussing the past and the present of diagnostic EM, (2) To describe the system of External Quality Assessment on EM virus diagnosis (EQA-EMV) established in 1994 by our laboratory and its achievements. STUDY DESIGN: EQA-EMV is run to evaluate, to confirm and to improve the quality of diagnostic EM. Two different types of specimen are sent out: (1) prepared grids to assess and train the diagnostic skills of the participants, (2) stabilized virus particle suspensions to assess preparation efficiency. RESULTS: Diagnostic EM differs from other diagnostic tests in its rapidity and its undirected 'open view'. To emphasize these advantages, the indications for diagnostic EM are discussed, fundamental for a continuing future adaptation. Besides appropriate techniques, quality control measures are required to achieve and keep high diagnostic standards. The results from 6 years of EQA-EMV are presented. CONCLUSIONS: In the history of diagnostic EM in virology, a change in use has been seen. Starting in the 1990s and coincident with the broad introduction of 'modern' diagnostic techniques, the number of EM diagnostic labs has decreased considerably--in spite of the obvious advantages of this technique. To guarantee the continuing performance of diagnostic EM in the future. EQA runs have to be performed as with other techniques in the diagnostic armament. The growing number of participants and participating countries indicates an interest in as well as a need for this program.


Subject(s)
Microscopy, Electron/trends , Virus Diseases/diagnosis , Animals , Humans , Microscopy, Electron/methods , Time Factors
16.
Virology ; 258(2): 425-34, 1999 Jun 05.
Article in English | MEDLINE | ID: mdl-10366580

ABSTRACT

A cytopathic infectious agent was isolated from the kidneys of an apparently healthy tree shrew (Tupaia belangeri) that had been captured in the area around Bangkok. The infectivity was propagated in Tupaia fibroblast and kidney cell cultures. Paramyxovirus-like pleomorphic enveloped particles and helical nucleocapsids were observed by electron microscopy and accordingly the infectious agent was termed Tupaia paramyxovirus (TPMV). However, no serological cross-reactions were detected between TPMV and known paramyxoviruses. For the molecular characterization of TPMV an experimental strategy that allows the random-primed synthesis of relatively large cDNA molecules from viral genomic RNA was applied. Nucleotide sequence analysis of a TPMV-specific cDNA fragment (1544 bp) revealed two nonoverlapping partial open reading frames corresponding to paramyxoviral N and P transcription units. Using modified rapid amplification of cDNA ends techniques, a substantial contiguous portion of the viral genome (4065 nt) was elucidated including the complete N and P/V/C genes. The coding strategy of TPMV as well as significant amino acid sequence homologies clearly indicates an evolutionary relationship between TPMV and members of the genus Morbillivirus. Highest homologies were detected between TPMV and Hendra virus (equine morbillivirus), which recently emerged in Australia, causing outbreaks of fatal respiratory and neurological disease in horses and humans.


Subject(s)
Respirovirus Infections/veterinary , Respirovirus/genetics , Tupaia/virology , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cloning, Molecular , Conserved Sequence , Cytopathogenic Effect, Viral , DNA, Complementary , DNA, Viral , Genes, Viral , Humans , Molecular Sequence Data , Phylogeny , Protein Sorting Signals , Rabbits , Respirovirus/classification , Respirovirus/isolation & purification , Respirovirus/pathogenicity , Respirovirus Infections/virology , Sequence Analysis, DNA , Transcription, Genetic , Viral Proteins/genetics
17.
Biol Chem ; 380(3): 325-33, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10223335

ABSTRACT

Core particles of the hepatitis B virus (HBV) potentiate the immune response against foreign epitopes presented on their surface. Potential insertion sites in the monomeric subunit of the HBV core protein were previously identified at the N- and C-terminus and in the immunodominant c/e1 region. In a C-terminally truncated core protein these sites were used to introduce the entire 120 amino acid (aa)-long potentially immunoprotective region of the hantavirus (serotype Puumala) nucleocapsid protein. The N- and C-terminal fusion products were unable to form core-like particles in detectable amounts. However, a suppressable stop codon located between the HBV core and the C-terminally fused hantavirus sequence restored the ability to form particles ('mosaic particles'); in contrast to the C-terminal fusion product the mosaic construct allowed the formation of particles built up by the core protein itself and the HBV core-Puumala nucleocapsid-readthrough protein. The mosaic particles exposed the 120 aa region of the PUU nucleocapsid protein on their surface as demonstrated by ELISA and immuno electron microscopy applying different monoclonal antibodies. Insertion of the hantaviral sequence into the c/e1 region not only allowed the formation of chimeric particles, but again the surface accessibility of the sequence. HBV core antigenicity itself was, however, reduced in the particles carrying insertions in the c/e1 region, probably due to a masking effect of the 120 aa long insert.


Subject(s)
Hepatitis B Core Antigens/immunology , Hepatitis B virus/immunology , Nucleocapsid/immunology , Orthohantavirus/immunology , Animals , Binding Sites , Hepatitis B Core Antigens/genetics , Humans , Nucleocapsid/genetics , Nucleocapsid Proteins , Rabbits , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Virion
18.
Biochimie ; 80(8-9): 745-54, 1998.
Article in English | MEDLINE | ID: mdl-9865497

ABSTRACT

IFN alpha causes a modest reduction of HIV-1 expression in chronically infected monocytoid U937 cells. However, the ratio between cell-associated and shed viral p24 antigen is altered, being the cell-associated fraction dose-dependently enhanced by IFN. Furthermore, a significant decrease of infectivity of both cell-associated and shed material is observed. Transmission electron microscopy of IFN-treated cells revealed virus assembly being strongly inhibited, with the production of morphologically altered (tear-drop shaped) virus particles. Proteolytic processing of gag proteins appeared to be normal in IFN-treated cultures. However, virions shed from IFN-treated cells showed a markedly reduced incorporation of virus-specific gp120 and cell-derived ICAM-1 by the virus envelope. Additionally, these particles showed a significantly decreased ability to become bound to CD4+ target cells, accounting for, at least in part, the observed decrease of infectivity. Taken together, the data suggest that, in chronically infected cells, IFN alpha can affect late stages of HIV-1 replication, by inhibiting virus assembly and release, and by reducing the infectivity of shed virions. The latter effect seems to be due, at least in part, to altered incorporation of surface glycoproteins and defective particle formation. The relationship between impaired gp120 incorporation and altered morphogenesis of HIV-1 virions is under investigation.


Subject(s)
Antiviral Agents/pharmacology , HIV-1/drug effects , Interferon-alpha/pharmacology , Virus Replication , Gene Products, gag/metabolism , Genome, Viral , HIV Core Protein p24/metabolism , HIV Envelope Protein gp120/metabolism , HIV-1/physiology , Humans , Protein Precursors/metabolism , Protein Processing, Post-Translational , Time Factors , U937 Cells , Virus Assembly
19.
Appl Environ Microbiol ; 64(11): 4128-33, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9797256

ABSTRACT

In recent years interest in bacteriophages in aquatic environments has increased. Electron microscopy studies have revealed high numbers of phage particles (10(4) to 10(7) particles per ml) in the marine environment. However, the ecological role of these bacteriophages is still unknown, and the role of the phages in the control of bacterioplankton by lysis and the potential for gene transfer are disputed. Even the basic questions of the genetic relationships of the phages and the diversity of phage-host systems in aquatic environments have not been answered. We investigated the diversity of 22 phage-host systems after 85 phages were collected at one station near a German island, Helgoland, located in the North Sea. The relationships among the phages were determined by electron microscopy, DNA-DNA hybridization, and host range studies. On the basis of morphology, 11 phages were assigned to the virus family Myoviridae, 7 phages were assigned to the family Siphoviridae, and 4 phages were assigned to the family Podoviridae. DNA-DNA hybridization confirmed that there was no DNA homology between phages belonging to different families. We found that the 22 marine bacteriophages belonged to 13 different species. The host bacteria were differentiated by morphological and physiological tests and by 16S ribosomal DNA sequencing. All of the bacteria were gram negative, facultatively anaerobic, motile, and coccoid. The 16S rRNA sequences of the bacteria exhibited high levels of similarity (98 to 99%) with the sequences of organisms belonging to the genus Pseudoalteromonas, which belongs to the gamma subdivision of the class Proteobacteria.


Subject(s)
Bacteria/virology , Caudovirales/classification , Seawater/virology , Caudovirales/isolation & purification , Caudovirales/ultrastructure , Oceans and Seas , Phylogeny , Polymerase Chain Reaction/methods , RNA, Ribosomal, 16S/genetics
20.
Virus Genes ; 17(1): 49-53, 1998.
Article in English | MEDLINE | ID: mdl-9778788

ABSTRACT

Recently the UL56 protein of herpes simplex virus type 1 (HSV-1) was shown to be associated with the virion of HSV-1 as determined by Western blot analysis. The detection of the UL56 protein in infected cells and its association with virions of HSV-1 is of particular importance, pointing to a possible involvement of UL56 protein in virus-host interactions. In order to investigate the properties of the UL56 protein further immuno-localization was performed using rabbit hyperimmune serum against fusion recombinant UL56 protein and purified virions of HSV-1 strain F. The UL56 protein was detected in the HSV-1 virions by immuno gold negative staining.


Subject(s)
Herpesvirus 1, Human/ultrastructure , Viral Proteins/analysis , Virion/ultrastructure , Herpesvirus 1, Human/chemistry , Immunoblotting , Microscopy, Immunoelectron , Virion/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...